Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Crawford

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Immunology|November 16, 2020
IL-12-Induced Immune Suppressive Deficit During CD8+ T-Cell DifferentiationPranav S Renavikar, Sushmita Sinha, Ashley A Brate, et al.
Journal of Clinical Apheresis|February 7, 2026
Suppressive CD8+ T-Cells Are Key Cellular Mediators of Extracorporeal PhotopheresisKai J Rogers, Kathryn L Eschbacher, Zeb Zacharias, et al.
Clinical Immunology (Orlando, Fla.)|May 8, 2016
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosisImran H Mohiuddin, Vinodh Pillai, Ethan J Baughman, et al.
Scientific Reports|October 20, 2018
An autoimmune disease risk SNP, rs2281808, in SIRPG is associated with reduced expression of SIRPγ and heightened effector state in human CD8 T-cellsSushmita Sinha, Nicholas Borcherding, Pranav S Renavikar, et al.
Plos One|August 28, 2020
Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cellsSushmita Sinha, Pranav S Renavikar, Michael P Crawford, et al.
Blood|February 21, 2004
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assayMichael P Crawford, Shirley X Yan, Sterling B Ortega, et al.
The Journal of Clinical Investigation|March 6, 2002
Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosisNitin J Karandikar, Michael P Crawford, Xiao Yan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Frontiers in Immunology|November 16, 2020
IL-12-Induced Immune Suppressive Deficit During CD8+ T-Cell DifferentiationPranav S Renavikar, Sushmita Sinha, Ashley A Brate, et al.
Journal of Clinical Apheresis|February 7, 2026
Suppressive CD8+ T-Cells Are Key Cellular Mediators of Extracorporeal PhotopheresisKai J Rogers, Kathryn L Eschbacher, Zeb Zacharias, et al.
Clinical Immunology (Orlando, Fla.)|May 8, 2016
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosisImran H Mohiuddin, Vinodh Pillai, Ethan J Baughman, et al.
Scientific Reports|October 20, 2018
An autoimmune disease risk SNP, rs2281808, in SIRPG is associated with reduced expression of SIRPγ and heightened effector state in human CD8 T-cellsSushmita Sinha, Nicholas Borcherding, Pranav S Renavikar, et al.
Plos One|August 28, 2020
Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cellsSushmita Sinha, Pranav S Renavikar, Michael P Crawford, et al.
Blood|February 21, 2004
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assayMichael P Crawford, Shirley X Yan, Sterling B Ortega, et al.
The Journal of Clinical Investigation|March 6, 2002
Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosisNitin J Karandikar, Michael P Crawford, Xiao Yan, et al.
Pageof 2